Mindray Competitors and Similar CompaniesClear all
Mindray's competitors and similar companies include Lepu Medical Technology, Weigao Group, GE Global Research, Abbott, Roche, Danaher, GE HealthCare, Hitachi, Sysmex and United Imaging Healthcare.
 Mindray Mindray (迈瑞, also known as Shenzhen Mindray Bio-medical Electronics, 江苏鼎智智能控制科技股份有限公司) is a company that develops, manufacturers, and markets medical devices for human and veterinary use. |  Lepu Medical Technology Lepu Medical Technology is a company that specializes in developing, manufacturing, and distributing medical devices and equipment. |  Weigao Group Shandong Weigao Group Medical Polymer (山東威高集團醫用高分子製品股份有限公司) is a company engaged in the research, development, production, and sale of single-use medical devices. |  Abbott Abbott Laboratories is a company that specializes in the discovery, development, manufacture, and sale of healthcare products. |  Danaher Danaher (formerly known as Diversified Mortgage Investors) is a life sciences and diagnostics company that manages and operates its group companies. |  GE HealthCare GE HealthCare Technologies (formerly known as GE Healthcare Holding) is a company that provides medical systems and solutions. |  Hitachi Hitachi (株式会社日立製作所) is a conglomerate of companies that provides digital systems, green energy and mobility, and connective solutions. |  United Imaging Healthcare Shanghai United Imaging Healthcare (上海联影医疗科技股份有限公司) is a company that provides diagnostics, radiotherapy, and healthcare information technology solutions. | ||||
Founding Date | Founding Date 1991 | Founding Date 1999 | Founding Date 1988 | Founding Date 1900 | Founding Date 1888 | Founding Date 1896 | Founding Date 1984 | Founding Date 1892 | Founding Date 1910 | Founding Date 1968 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||||||
Locations | Locations Shenzhen, CN HQ Buenos Aires, AR Melbourne, AU Sao Paulo, BR Burnaby, CA Richmond Hill, CA Santiago, CL see more | Locations Beijing, CN HQ Heerenveen, NL | Locations Weihai, CN HQ | Locations Niskayuna, US HQ Rio De Janeiro, BR Shanghai, CN Garching Bei München, DE Bengaluru, IN San Ramon, US | Locations Abbott Park, US HQ Tiranë, AL Buenos Aires, AR Yerevan, AM Doncaster, AU East Brisbane, AU Macquarie Park, AU see more | Locations Washington, US HQ Mount Waverley, AU Vienna, AT Ghent, BE Sao Paolo, BR Vancouver, CA Shanghai, CN see more | Locations Chicago, US HQ El Biar, DZ Parramatta, AU Tiefenbach, AT Wien, AT Machelen, BE Contagem, BR see more | Locations Tokyo, JP HQ Buenos Aires, AR East Arm, AU Fortitude Valley, AU Lilydale, AU Perth, AU Smithfield, AU see more | Locations Kobe, JP HQ Sydney, AU Wien, AT Hoeilaart, BE Sao Jose, BR Ouagadougou, BF Mississauga, CA see more | Locations Shanghai, CN HQ Melbourne, AU Changzhou, CN Wuhan, CN Tokyo, JP Seoul, KR Kuala Lumpur, MY see more | |
Employees | Employees 21,66720% increase | Employees 8,81214% decrease | Employees 13,0633% increase | Employees 1,0281% decrease | Employees 114,000 | Employees 103,249 | Employees 60,0002% decrease | Employees 54,0002% increase | Employees 282,7435% increase | Employees 10,042 | Employees 8,173 |
Valuation ($) | Valuation ($) 46.1 b | Valuation ($) 3.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 196.1 b | Valuation ($) N/A | Valuation ($) 175.3 b | Valuation ($) 38.9 b | Valuation ($) 107.2 b | Valuation ($) 11.6 b | Valuation ($) N/A |
Financial | |||||||||||
Revenue (est.) | Revenue (est.) ¥30.4b (FY, 2022) | Revenue (est.) ¥6.3b (FY, 2025) | Revenue (est.) ¥13.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $44.3b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) $24.6b (FY, 2025) | Revenue (est.) $20.6b (FY, 2025) | Revenue (est.) ¥10.6t (FY, 2026) | Revenue (est.) ¥508.6b (FY, 2025) | Revenue (est.) ¥13.1b (FY, 2025) |
Cost of goods | Cost of goods ¥88 (FY, 2022) | Cost of goods ¥2.3b (FY, 2025) | Cost of goods ¥6b (FY, 2025) | Cost of goods N/A | Cost of goods $19.3b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods $10b (FY, 2025) | Cost of goods $12.4b (FY, 2025) | Cost of goods ¥6.9t (FY, 2026) | Cost of goods ¥197.6b (FY, 2025) | Cost of goods ¥7.3b (FY, 2025) |
Gross profit | Gross profit ¥30.4b (FY, 2022) | Gross profit ¥4.1b (FY, 2025) | Gross profit ¥7.5b (FY, 2025) | Gross profit N/A | Gross profit $25b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit $14.5b (FY, 2025) | Gross profit $8.2b (FY, 2025) | Gross profit ¥3.8t (FY, 2026) | Gross profit ¥312.8b (FY, 2025) | Gross profit ¥6.4b (FY, 2025) |
Net income | Net income ¥8b (FY, 2022) | Net income ¥1b (FY, 2025) | Net income ¥1.7b (FY, 2025) | Net income N/A | Net income $6.5b (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income $3.6b (FY, 2025) | Net income $2.2b (FY, 2025) | Net income ¥851.4b (FY, 2026) | Net income ¥53.6b (FY, 2025) | Net income ¥1.8b (FY, 2025) |
Operating ⚠ | |||||||||||
Countries | Countries 190 (Sep, 2023) | Countries 40 (Sep, 2023) | Countries N/A | Countries N/A | Countries N/A | Countries N/A | Countries 50 (FY, 2023) | Countries 17 (FY, 2022) | Countries N/A | Countries 190 (FY, 2018) | Countries N/A |
Facilities | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A | Facilities 184 (FY, 2023) | Facilities 336 (FY, 2022) | Facilities N/A | Facilities N/A | Facilities N/A |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 1.1 k (FY, 2023) | Manufacturing Facilities 9 (FY, 2018) | Manufacturing Facilities N/A |
Products | Products 19 (Sep, 2023) | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products 6 (May, 2023) |
Remaining Performance Obligations | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations $4.5b (Q2, 2024) | Remaining Performance Obligations $14.2b (Q3, 2023) | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A |
Funding | |||||||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 12.6m | Total funding raised N/A | Total funding raised $ 7.8b | Total funding raised N/A | Total funding raised $ 5.6b | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 503.9m |
For sources of this data, please see the company profile
View Company Profiles
Lepu Medical Technology
HQ
Beijing, CN
Employees
8,812↓ 14% decrease
Lepu Medical Technology is a company that specializes in developing, manufacturing, and distributing medical devices and equipment.
View companyWeigao Group
HQ
Weihai, CN
Employees
13,063↑ 3% increase
Shandong Weigao Group Medical Polymer (山東威高集團醫用高分子製品股份有限公司) is a company engaged in the research, development, production, and sale of single-use medical devices.
View company
GE Global Research
HQ
Niskayuna, US
GE Global Research is an innovation organization operated by General Electric.
View companyAbbott
HQ
Abbott Park, US
Employees
114,000
Abbott Laboratories is a company that specializes in the discovery, development, manufacture, and sale of healthcare products.
View company